Soluble ACE2 (sACE2) from ACE2 cleaved by ADAM17 is used as a decoy receptor to trap spikes of virus to prevent cellular engagement for COVID-19 therapy (Monteil et al., 2020; Jia et al., 2009). Here, ADAM17 is linked to COVID-19.